Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 163.06 million shares for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 155.63 million shares | Q2 2019: 156.44 million shares | Q3 2019: 156.81 million shares | Q1 2020: 159.37 million shares | Q2 2020: 159.98 million shares | Q3 2020: 160.08 million shares | Q1 2021: 161.93 million shares | Q2 2021: 162.83 million shares | Q3 2021: 163.41 million shares | Q1 2022: 155.12 million shares | Q2 2022: 153.18 million shares | Q3 2022: 153.32 million shares | Q1 2023: 155.35 million shares | Q2 2023: 156.03 million shares | Q3 2023: 156.13 million shares | Q1 2024: 158.96 million shares | Q2 2024: 159.74 million shares | Q3 2024: 160.02 million shares | Q1 2025: 161.81 million shares | Q2 2025: 162.43 million shares | Q3 2025: 162.68 million shares.
- Over the full 8 years of available data (2018 to 2025), IRONWOOD PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 5.6%.
- Historical annual values: Fiscal year 2025: 163.06 million shares | Fiscal year 2024: 160.21 million shares | Fiscal year 2023: 156.35 million shares | Fiscal year 2022: 154.03 million shares | Fiscal year 2021: 162.04 million shares | Fiscal year 2020: 160.62 million shares | Fiscal year 2019: 157.54 million shares | Fiscal year 2018: 154.41 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: